Andreas •

Andreas Amrein, a highly accomplished individual holding a PhD, MBA, and MSc, boasts an impressive background in international leadership with a focus on elevating profitability and performance in global Fortune 100 companies and dynamic start-ups such as Novartis, Abbott, Shire, and Takeda.

With over seven years of global experience and more than 13 years in Asia, Andreas has an extensive track record of managing large teams, exceeding P&L responsibilities exceeding USD 1.4 billion, and driving business improvements and expansions in over 30 countries across Asia, North America, and Europe.

His expertise spans various key areas including sales, marketing, business development, strategy, and finance, with a specialization in leading market expansions, forging profitable partnerships, and driving M&A leadership, due diligence processes, and investment strategies.

Andreas has held notable positions such as JAPAC Region Head, General Manager for Japan, China, and South Korea, Director of the Board, and has excelled in leading transformations, strategic planning, commercialization, marketing, sales leadership, finance, governance & compliance, business development, M&A, customer/patient support, and multiple therapeutic areas.

He has a diverse educational background having studied programs in M&A, Strategy, Negotiations, Executive Finance, Executive Marketing, and rare diseases, health economics, evidence-based medicine, and quality of life.

Additionally, Andreas has held strategic roles in renowned organizations including Vice President at Takeda, Shire, President at Accutest Research Laboratories (I) Pvt. Ltd., and various executive and managerial positions at Abbott, Novartis Pharma, and UBS.

His professional journey also includes experience as a Financial Analyst at UBS and a Commander, Captain Artillery Battery in the Swiss Armed Forces.